Skip to main content
Retour
Watch Compare

Eloxx Pharmaceuticals, Inc.

Qualité des données : 100%
ELOX
OTC Manufacturing Chemicals
0,08 €
▼ 0,02 € (-20,08%)
Cap. Boursière: 405 754,0
Prix
0,08 €
Cap. Boursière
405 754,0
Fourchette du Jour
0,08 € — 0,08 €
Fourchette 52 Semaines
0,00 € — 0,75 €
Volume
12
Ouverture 0,08 €
Moyenne 50J / 200J
0,04 €
113,33% above
Moyenne 50J / 200J
0,01 €
751,06% above

Quick Summary

Points Clés

Negative free cash flow of -6,33 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,24
Interest CoverageN/A

Valorisation

PE (TTM)
-0,07
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -6,00 M
ROE N/A ROA -99,63%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -6,33 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,24
Interest Coverage N/A Asset Turnover 0,00
Working Capital -17,84 M Tangible Book Value -20,05 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,07 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1559,32%
Market Cap 405 754,0 Enterprise Value 251 754,0
Per Share
EPS (Diluted TTM) -0,49 Revenue / Share 0,00
FCF / Share -1,25 OCF / Share -1,25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 105,54%
SBC-Adj. FCF -8,67 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2022 FY2021 FY2020 FY2019
Revenue 0,0 — — — —
Net Income -6,00 M -36,07 M -66,73 M -34,58 M -50,87 M
EPS (Diluted) -0,49 -16,65 — — —
Gross Profit — — — — —
Operating Income -6,44 M -34,42 M -66,02 M -33,46 M -50,56 M
EBITDA — — — — —
R&D Expenses — — — 14,59 M 25,84 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2022 FY2021 FY2020 FY2019
Total Assets 5,27 M 21,12 M 45,14 M 26,48 M 58,95 M
Total Liabilities 17,18 M 31,78 M 22,76 M 16,25 M 22,73 M
Shareholders' Equity -11,91 M -10,66 M 22,38 M 10,23 M 36,21 M
Total Debt 1,00 M 11,72 M 11,18 M 10,72 M 13,94 M
Cash & Equivalents 4,79 M 19,21 M 42,27 M 24,67 M 22,49 M
Current Assets 5,27 M 20,13 M 43,48 M 25,89 M 57,71 M
Current Liabilities 17,18 M 23,09 M 9,96 M 9,84 M 11,81 M